Is a Combination of a GnRH Agonist and Recombinant Growth Hormone an Effective Treatment to Increase the Final Adult Height of Girls with Precocious or Early Puberty?

The aim of treatment for idiopathic central precocious puberty (ICPP) is to increase final adult stature, for which gonadotropin-releasing hormone agonist (GnRHa) is the gold standard. Early puberty is frequently similar to ICPP, with pubertal onset only slightly advanced. Short stature may result f...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Wei, Zhao, Fei, Liang, Shuang, Li, Guimei, Xue, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332953/
https://www.ncbi.nlm.nih.gov/pubmed/30693027
http://dx.doi.org/10.1155/2018/1708650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332953/
https://www.ncbi.nlm.nih.gov/pubmed/30693027
http://dx.doi.org/10.1155/2018/1708650

Ejemplares similares